SINGAPORE, Sept. 15, 2025 /PRNewswire/ -- Supported by six clinical studies and two safety trials, Kerry's LC40® is the first probiotic…
- Phase 3 Trial Informed by KARDIA-3 Phase 2 Study Results Presented as a Late-Breaking Abstract at the European Society…
SAN CLEMENTE, Calif., Aug. 20, 2025 /PRNewswire/ -- Angelalign Technology Inc. (6699.HK) ("Angel") categorically denies accusations of patent infringement by Align Technology Inc.…
- Presentations highlight clinically meaningful reductions in BMI in patients with acquired hypothalamic obesity – - Full data from Phase…
Data presented simultaneously at the American Diabetes Association’s® 85th Scientific Sessions, showed mean weight reduction in the highest range of…
ST. LOUIS--(BUSINESS WIRE)--EyeCare Partners (ECP), the nation’s leading provider of clinically integrated eye care, released its first Quality and Outcomes…